IL13 and metabolic dysfunction-associated steatotic liver disease: On univariate analysis, MCI in the NAFLD patients was significantly associated with the plasma levels of IL-13 and the percentage of activated autoreactive cells (CD4+CD28− CD69+) (Table 2).